MedPath

ong term physical activity in rheumatoid arthritis

Not Applicable
Completed
Conditions
Rheumatology and physical therapy
Musculoskeletal Diseases
Registration Number
ISRCTN25539102
Lead Sponsor
Karolinska Institute
Brief Summary

2012 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/22656861 Study protocol 2018 Results article in http://www.ncbi.nlm.nih.gov/pubmed/29544539 Pain substudy #I 2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30477552 Pain substudy #II 2014 Other publications in https://pubmed.ncbi.nlm.nih.gov/24124063/ Selection procedure (added 12/01/2022) 2017 Results article in https://pubmed.ncbi.nlm.nih.gov/29143384/ Cardiovascular substudy #I (added 12/01/2022) 2018 Results article in https://pubmed.ncbi.nlm.nih.gov/29799295/ Cardiovascular substudy #II (added 12/01/2022) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34977091/ Cardiovascular substudy #III (added 12/01/2022) 2014 Results article in https://pubmed.ncbi.nlm.nih.gov/24941928/ Experiences of PA participation (added 12/01/2022) 2014 Results article in https://pubmed.ncbi.nlm.nih.gov/25433043/ PA intervention, 1 year (added 12/01/2022) 2018 Results article in https://pubmed.ncbi.nlm.nih.gov/29717033/ PA intervention, 2 years (added 12/01/2022) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32975562/ Perceptions of PA maintenance (added 12/01/2022)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
249
Inclusion Criteria

1. Rheumatoid arthritis according to American College of Rheumatology 1987 criteria
2. Aged between 18 - 74 years, either sex
3. Disease duration over one year
4. Independence in daily living
5. Recommended levels of health enhancing physical activity (HEPA) not currently reached

Exclusion Criteria

1. Problems with speaking and understanding Swedish
2. Other major diseases preventing HEPA

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
General Health Perception Visual Analogue Scale (VAS), assessed at baseline and after one and two years respectively
Secondary Outcome Measures
NameTimeMethod
<br> Each outcome will be assessed at baseline and after one and two years respectively:<br> 1. Pain<br> 2. Fatigue<br> 3. Fear avoidance beliefs<br> 4. Exercise self-efficacy<br> 5. Muscle function<br> 6. Aerobic capacity<br> 7. Systemic and local inflammatory activity<br> 8. Pain sensitivity<br> 9. Cardiovascular events<br>
© Copyright 2025. All Rights Reserved by MedPath